Some studies have also reported that CK5+ breast cancer cells possess CSC-like properties and that progesterone treatment can induce the conversion of ER+/PR+/CK5− cells to ER−/PR−/CK5+ cells, which represent a relatively quiescent state, leading to resistance to endocrine therapy and chemotherapy (45–47). This evidence concerns the gene ESR1 and breast carcinoma.